Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
120
TGA:110
NMPA:10
Drug Approvals
Acalabrutinib Maleate Tablets
- Product Name
- 马来酸阿可替尼片
- Approval Number
- 国药准字HJ20240118
- Approval Date
- Oct 29, 2024
NMPA
Budesonide Suspension for Inhalation
- Product Name
- 普米克令舒
- Approval Number
- 国药准字HJ20140474
- Approval Date
- Nov 30, 2023
NMPA
Budesonide Suspension for Inhalation
- Product Name
- 普米克令舒
- Approval Number
- 国药准字HJ20140475
- Approval Date
- Nov 30, 2023
NMPA
Omeprazole Magnesium Enteric-coated Tablets
- Product Name
- 洛赛克MUPS
- Approval Number
- 国药准字HJ20181233
- Approval Date
- Feb 13, 2023
NMPA
Omeprazole Magnesium Enteric-coated Tablets
- Product Name
- 洛赛克MUPS
- Approval Number
- 国药准字HJ20181234
- Approval Date
- Feb 13, 2023
NMPA
Omeprazole Magnesium Enteric-coated Tablets
- Product Name
- 洛赛克MUPS
- Approval Number
- 国药准字HJ20181232
- Approval Date
- Feb 13, 2023
NMPA
Omeprazole Magnesium Enteric-coated Tablets
- Product Name
- 洛赛克MUPS
- Approval Number
- 国药准字HJ20181231
- Approval Date
- Feb 13, 2023
NMPA
Budesonide Suspension for Inhalation
- Product Name
- 普米克令舒
- Approval Number
- H20140475
- Approval Date
- May 22, 2019
NMPA
Budesonide Suspension for Inhalation
- Product Name
- 普米克令舒
- Approval Number
- H20140474
- Approval Date
- May 22, 2019
NMPA
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)No trials found
News
No news found